Patrick G. Enright is Director at Jazz Pharmaceuticals plc (JAZZ). They have made 53 open-market trades across 10 companies since 2009, most recently 2026-08-05.
21 open-market purchases totalling $110.2M since 2009, against 32 sales. Across 21 scored buys the stock is up 2.1% at ninety days, and 0.1 points behind the S&P over the same stretch.
21 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 38% | 29% |
| Avg Move | -0.7% | +4.3% | +2.1% |
| Alpha | +0.4% | +3.1% | -0.1% |
| Scored | 21 | 21 | 21 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | -19.0% | -7.7% | -5.8% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MANE | BUY | 2026-02-05 | 2026-02-05 | $17.00 | $18.3M | +35.4% | +38.7% | +197.4% |
| VERA | BUY | 2025-12-11 | 2025-12-15 | $42.50 | $250K | +8.0% | -2.5% | -19.3% |
| ZBIO | BUY | 2025-10-09 | 2025-10-14 | $19.34 | $2.5M | -10.9% | +33.0% | -26.2% |
| VERA | BUY | 2025-06-23 | 2025-06-25 | $21.11 | $10.6M | -8.2% | -13.0% | +3.6% |
| BIOA | BUY | 2024-09-27 | 2024-09-27 | $18.00 | $7.2M | -10.9% | +7.4% | -73.9% |
| ZBIO | BUY | 2024-09-16 | 2024-09-16 | $17.00 | $7.5M | -3.8% | +8.4% | -51.2% |
| JAZZ | SELL | 2023-08-14 | 2023-08-15 | $138.16 | $343K | +1.5% | -3.8% | -12.3% |
| VERA | BUY | 2023-02-06 | 2023-02-08 | $7.00 | $12.0M | +4.0% | -4.7% | -1.2% |
| JAZZ | SELL | 2022-11-22 | 2022-11-25 | $150.05 | $1.8M | -0.4% | +4.4% | -3.7% |
| JAZZ | SELL | 2022-08-08 | 2022-08-09 | $152.33 | $332K | -0.7% | -3.9% | -7.8% |
| VERA | BUY | 2022-02-10 | 2022-04-05 | $15.00 | $5.0M | +0.5% | -19.6% | -39.7% |
| VERA | BUY | 2021-05-18 | 2021-05-18 | $11.00 | $10.0M | +37.2% | +22.7% | +35.2% |
| JAZZ | SELL | 2020-11-12 | 2020-11-13 | $146.61 | $2.2M | -3.6% | +1.5% | +13.4% |
| AIMT | BUY | 2020-03-17 | 2020-03-19 | $11.34 | $1.7M | +12.5% | +31.6% | +48.2% |
| APTX | BUY | 2020-01-10 | 2020-01-14 | $3.00 | $785K | +24.3% | -4.7% | -32.6% |
| JAZZ | SELL | 2019-08-09 | 2019-08-12 | $135.65 | $197K | -3.2% | -1.3% | -3.1% |
| AXNX | BUY | 2018-11-02 | 2018-11-02 | $15.00 | $8.0M | -0.1% | -7.5% | -3.6% |
| JAZZ | SELL | 2018-09-06 | 2018-09-07 | $168.71 | $3.2M | -2.8% | -3.4% | -14.5% |
| JAZZ | SELL | 2018-08-10 | 2018-08-13 | $175.13 | $478K | -3.5% | -5.6% | -15.5% |
| APTX | BUY | 2018-06-25 | 2018-06-26 | $16.00 | $2.4M | +20.3% | +10.5% | +31.9% |
| AIMT | BUY | 2018-02-22 | 2018-02-26 | $32.00 | $499K | +12.1% | +2.9% | +4.8% |
| JAZZ | SELL | 2017-12-11 | 2017-12-13 | $139.67 | $2.0M | -4.0% | +6.6% | +7.1% |
| JAZZ | SELL · 10b5-1 | 2017-11-17 | 2017-11-21 | $133.19 | $47K | -0.7% | -2.9% | +5.3% |
| JAZZ | SELL | 2017-08-25 | 2017-08-28 | $148.40 | $104K | +3.9% | +1.8% | -5.7% |
| JAZZ | SELL | 2017-08-11 | 2017-08-14 | $142.36 | $188K | +2.7% | +5.7% | -5.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ESPR | 922,112 | $2.9M |
| MTEM | 3,199,035 | $343K |
| ZBIO | 11,990 | $299K |
| VERA | 5,882 | $164K |
| APTX | 95,000 | $15K |
| EAR | 5,012 | $13K |
| THLD | 496 | $3K |
| SQNM | 771 | $2K |
| Total | $443.9M |
Shares reported on the most recent Form 4, priced at the 2026-08-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 6 | 6 | 6 |